
About Primas Bioscience Private Limited
Data last updated:
Primas Bioscience Private Limited is a private limited company based in Chennai, Tamil Nadu, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U36999TN2019PTC129400. Its GSTIN is 33AAKCP5600L1ZD (Tamil Nadu).
The company has an authorised share capital of ₹65 Lakh and a paid-up capital of ₹19.33 Lakh. It is led by directors including Chandhrasekaran Kabilan (Managing Director) and Dhanraj Muthu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A2 – 404 Adroit District 'S' Palandi Amman Koil Street Thalambur, Chennai, Tamil Nadu, India – 600130.
As per the financials filed for FY 2025, the company reported a revenue of ₹92.2 Lakh, a growth of 150% compared to the previous year. For the same year it recorded a net loss of ₹1.71 Cr (net margin -185.4%) and EBITDA of -₹67.81 Lakh (EBITDA margin -73.6%). Revenue has grown at a compounded annual rate (CAGR) of 840% over three years.
The company is associated with 1 brand: Primas Bioscience. As per MCA filings, the company has open charges of ₹3.88 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
Primas Bioscience Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0177169). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website primasbioscience.com.
Company details
Recognitions & Rankings of Primas Bioscience
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-02-0177169
Contact details
Primas Bioscience Private Limited's registered office is in Chennai, Tamil Nadu. Its website is primasbioscience.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressA2 – 404 Adroit District 'S' Palandi Amman Koil Street Thalambur, Chennai, Tamil Nadu, India – 600130
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Primas Bioscience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Primas Bioscience operates one associated brand: Primas Bioscience. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Developer of omega 3 fatty acids & nutritional supplements | primasbioscience.com |
Business activity
The main business activity of Primas Bioscience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Primas Bioscience Private Limited, buy the company report.
Financials of Primas Bioscience Private Limited
FY 2025 filings availablePrimas Bioscience Private Limited reported revenue of ₹92.2 Lakh (up 150% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 840% over three years, including 150% growth in the latest year. EBITDA rose 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹67.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.71 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -73.6% | ||||
| Net Profit Margin | -185.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Primas Bioscience Private Limited, buy the company report.
Board of directors of Primas Bioscience Private Limited
Primas Bioscience has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prabakaran | Additional Director | 19 Feb 2021 | 5 Years 8 Months | Current |
| Anju Chadha | Additional Director | 19 Feb 2021 | 5 Years 8 Months | Current |
| Chandhrasekaran Kabilan Also directs: Turos Beverages LLP | Managing Director | 22 May 2019 | 7 Years 5 Months | Current |
| Dhanraj Muthu Also directs: Turos Beverages LLP | Director | 22 May 2019 | 7 Years 5 Months | Current |
Peer comparison
Primas Bioscience Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| United Laboratories India Pvt Ltd | ₹92.31 Lakh (FY 2025) | -41.0% | Kolkata, West Bengal, India | |||
| Assort Laboratories Private Limited | ₹92.24 Lakh (FY 2017) | 38.0% | Patna, Bihar, India | |||
| Primas Bioscience Private Limitedthis company | ₹92.2 Lakh (FY 2025) | -₹1.71 Cr | -185.4% | 150.0% | Chennai, Tamil Nadu, India | |
| Skaipher Nutraceutical Limited | ₹91.73 Lakh (FY 2020) | 523.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Primas Bioscience Private Limited, buy the company report.
Auditor
Primas Bioscience Private Limited is audited by Kaushik V for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kaushik V | FY 2023 | 242040 |
Shareholding
The shareholding of Primas Bioscience Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Primas Bioscience Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Jan 2024 | 100870586 | Others | ₹50 Lakh | Open | |
| 28 Feb 2023 | 100683808 | Others | ₹3.38 Cr | Open |
Total charge records: 2 View all charges
Legal cases
Primas Bioscience Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Erode, Tamil Nadu | Criminal case | Filed against the company by Ms Rci Specailities Private Limited Rep by Its Director Mr R Haraganesh | Disposed |
To see the full case history of Primas Bioscience Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Primas Bioscience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Primas Bioscience Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
GST
Primas Bioscience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAKCP5600L1ZD | Tamil Nadu | Active | 09 Feb 2020 |
To see the full GST registrations and return filing status of Primas Bioscience Private Limited, buy the company report.
Recent activity
Primas Bioscience Private Limited has 5 board changes on record since 2019: 4 appointments and 1 cessation. The latest: Selvi ceased to be Additional Director on 30 Nov 2021.
Frequently asked questions
Primas Bioscience is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 May 2019 (7+ years old) and is registered under CIN U36999TN2019PTC129400.
Primas Bioscience has 4 current directors:
- Chandhrasekaran Kabilan - Managing Director
- Prabakaran - Additional Director
- Anju Chadha - Additional Director
- Dhanraj Muthu - Director
The latest financial statements of Primas Bioscience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Primas Bioscience is 33AAKCP5600L1ZD, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Primas Bioscience is U36999TN2019PTC129400. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Primas Bioscience has 1 court case on record: 1 filed against it.
Primas Bioscience was incorporated on 22 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Primas Bioscience by revenue are United Laboratories India Pvt Ltd, Assort Laboratories Private Limited, Skaipher Nutraceutical Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Selvi ceased to be Additional Director on 30 Nov 2021. Anju Chadha was appointed as Additional Director on 19 Feb 2021. Prabakaran was appointed as Additional Director on 19 Feb 2021. Primas Bioscience has 5 board changes on record in total.
Yes, Primas Bioscience is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Primas Bioscience is registered as a small enterprise under Udyam registration (number: UDYAM-TN-02-0177169).